Filing step-change
PHARMAID · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
Here is the rewritten narrative: Pharmaid's quarterly performance shows a significant improvement in its gross margin, accelerating to 39.76% as of October 21, 2026, up from -29.85% in the previous quarter.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 39.76 % | -29.85 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -29.85 % | -18 | ▼ |
Cite this
Source: Samhati filing step-change for PHARMAID (2026-10). Observation: Here is the rewritten narrative: Pharmaid's quarterly performance shows a significant improvement in its gross margin, accelerating to 39.76% as of October 21, 2026, up from -29.85% in the previous quarter. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/pharmaid/q/2026-10
Other periods